The panel, GLP-1s on the Rise: The Future of Diabetes, Weight Loss Care, will explore the transformative potential of GLP-1 receptor agonists in managing diabetes and obesity. Experts will discuss the clinical benefits, emerging research, and practical considerations for integrating these therapies into patient care. The session will also address the financial and operational implications for hospitals, including patient access, reimbursement strategies, and pharmacy workflows. Attendees will gain valuable insights into leveraging GLP-1 therapies to enhance outcomes and meet the growing demand for innovative diabetes and weight loss solutions.